Novocuff Secures $26M in Series A Funding to Advance Preterm Birth Solutions
Key Highlights Novocuff raises $26M Series A, led by AXA IM Alts. Funding supports U.S. pivotal clinical trial and…
Browsing Tag
AXA IM Alts
1 post